Edesa Biotech, Inc. (EDSA) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,4577,4718,2707,09112,80915,887
Cash and cash equivalents6,4577,4718,2707,09112,80915,887
Other undisclosed current assets4576588162,0012,3722,113
Total current assets:6,9148,1309,0879,09215,18018,000
Noncurrent Assets
Operating lease, right-of-use asset112128147183960
Property, plant and equipment101112131516
Intangible assets, net (including goodwill)2,2052,2312,2562,2812,3062,332
Intangible assets, net (excluding goodwill)2,2052,2312,2562,2812,3062,332
Deposits noncurrent assets      
Other undisclosed noncurrent assets 178174174171  
Total noncurrent assets:2,5052,5442,5882,4842,3612,408
TOTAL ASSETS:9,42010,67311,67511,57617,54120,408
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,4541,4991,2102,1225,6173,274
Accrued liabilities   22  
Other undisclosed accounts payable and accrued liabilities1,4541,4991,2102,1005,6173,274
Other undisclosed current liabilities756570194062
Total current liabilities:1,5291,5651,2802,1415,6573,335
Noncurrent Liabilities
Long-term debt and lease obligation    44  
Long-term debt, excluding current maturities    44  
Liabilities, other than long-term debt40109121 4748
Accounts payable and accrued liabilities  4444 4748
Operating lease, liability406477   
Total noncurrent liabilities:40109121444748
Total liabilities:1,5691,6741,4012,1845,7043,383
Equity
Equity, attributable to parent, including:7,8509,00010,2739,39111,83717,024
Common stock 46,14145,45444,474 40,26440,264
Additional paid in capital12,59812,49012,41811,17612,93012,364
Accumulated other comprehensive loss(190)(230)(239)(214)(126)(160)
Accumulated deficit(50,699)(48,714)(46,379)(44,045)(41,231)(35,444)
Other undisclosed equity, attributable to parent   42,473  
Total equity:7,8509,00010,2739,39111,83717,024
TOTAL LIABILITIES AND EQUITY:9,42010,67311,67511,57617,54120,408

Income Statement (P&L) ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
Revenues    780  
Cost of revenue
(Deferred Sales Inducement Cost, Amortization Expense)
   (30) (250)(250)
Other undisclosed gross profit    760  
Gross profit:   (30)1,540(250)(250)
Operating expenses(2,064)(2,411)(2,378)(2,836)(5,798) 
Other operating expense, net
(Other Expenses)
      (4,575)
Other undisclosed operating income (loss)   30(1,540)250250
Operating loss:(2,064)(2,411)(2,378)(2,836)(5,798)(4,575)
Nonoperating income (expense)797743(821)117
Loss, foreign currency transaction, before tax(3)(9)(6) (7) 
Loss from continuing operations before equity method investments, income taxes:(1,985)(2,334)(2,335)(3,658)(5,787)(4,569)
Other undisclosed income from continuing operations before income taxes    844  
Loss from continuing operations before income taxes:(1,985)(2,334)(2,335)(2,814)(5,787)(4,569)
Income tax expense  (1)   (1)
Loss from continuing operations:(1,985)(2,334)(2,335)(2,814)(5,787)(4,569)
Loss before gain (loss) on sale of properties:(2,814)(5,787)(4,569)
Other undisclosed net income   35,098  
Net income (loss):(1,985)(2,334)(2,335)32,284(5,787)(4,569)
Other undisclosed net loss attributable to parent   (35,098)  
Net loss available to common stockholders, diluted:(1,985)(2,334)(2,335)(2,814)(5,787)(4,569)

Comprehensive Income ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
Net income (loss):(1,985)(2,334)(2,335)32,284(5,787)(4,569)
Other undisclosed comprehensive loss    (17,557)  
Comprehensive income (loss):(1,985)(2,334)(2,335)14,727(5,787)(4,569)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent409(25)(17,628)3513
Comprehensive loss, net of tax, attributable to parent:(1,945)(2,326)(2,360)(2,902)(5,752)(4,556)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: